Interleukin-1 alpha (Amgen/Roche)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameInterleukin-1 alpha (Amgen/Roche)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A
Develop Information
Active CompaniesF. Hoffmann-La Roche LtdAmgen Inc
Inactive CompaniesN/A
Active Indications
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A